Neuren Pharmaceuticals

Neuren Pharmaceuticals (NEU)

Stock Code

NEU

Stock Exchange

ax

Neuren Pharmaceuticals (NEU) is a biopharmaceutical company focused on the development of human therapies for neuroprotection, metabolic deficiencies and growth-related disorders. The company was formed by the merger of NeuronZ Ltd and EndocrinZ Ltd effective 1 January 2004. It has established operations in Aukland, New Zealand where majority of its employees and consultants are based. It also has an office in Australia, and Maryland in the the US. Company listed on the Australian stockmarket (ASX) on 3 February, 2005.

Neuren Pharmaceuticals Dividends

18 October, 2010 - 01:12

Examine the list of historical dividends for Neuren Pharmaceuticals. The dividend a corporation pays is the amount of money, normally a portion of the profits, a board of directors distributes to the ordinary shareholders of the corporation. If Neuren Pharmaceuticals Limited has released a dividend, you may be eligible to receive NEU dividends if the trader the company's stock on the ex-dividend date. In order to receive the dividend payout, investors must purchase the stock before the ex dividend date.

Syndicate content

Recommended Websites